Last reviewed · How we verify
NCT07211919
Accelerated Transcranial Magnetic Stimulation Intervention for Post-Concussion Syndrome
trial in Post Concussive Syndrome, Chronic in 11 participants. Completed in 31 July 2025.
30 June 2025
Quick facts
| Lead sponsor | Cognitive FX |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 11 |
| Start date | 1 May 2025 |
| Primary completion | 30 June 2025 |
| Estimated completion | 31 July 2025 |
| Sites | 1 location across United States |
Conditions studied
- Post Concussive Syndrome, Chronic — all drugs for Post Concussive Syndrome, Chronic →
- Post Concussion Symptoms — all drugs for Post Concussion Symptoms →
- Post Concussive Syndrome — all drugs for Post Concussive Syndrome →
- Post Concussion Syndrome — all drugs for Post Concussion Syndrome →
Sponsor
Cognitive FX — full company profile →
Who can join
Adults 16 to 75, any sex, with Post Concussive Syndrome, Chronic or Post Concussion Symptoms. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study looks at the effects of accelerated intermittent theta burst stimulation (aiTBS) on patients with chronic and acute post-concussion syndrome. Each participant was treated in an outpatient setting for about 3 hours per day, over 3 days. The participants' symptom survey scores and brain scan data were then compared before and after treatment.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07211919
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Post Concussive Syndrome, Chronic
Currently open trials in the same condition.
- NCT07166536 — Symptom Exacerbation Following Mental Imagery in Patients With Persistent Post-Concussive Symptoms · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07211919 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cognitive FX
- Last refreshed: 10 October 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07211919.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing